NDC 0069-0297

TicoVac

Tick-borne Encephalitis Vaccine

TicoVac is a Intramuscular Injection in the Vaccine category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Tick-borne Encephalitis Purified Antigen (formaldehyde Inactivated).

Product ID0069-0297_989db61e-58f4-4685-9110-3e5c17a7fd57
NDC0069-0297
Product TypeVaccine
Proprietary NameTicoVac
Generic NameTick-borne Encephalitis Vaccine
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-06-27
Marketing CategoryBLA /
Application NumberBLA125740
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameTICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)
Active Ingredient Strength1 ug/.25mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0069-0297-02

1 SYRINGE in 1 CARTON (0069-0297-02) > .25 mL in 1 SYRINGE (0069-0297-01)
Marketing Start Date2022-06-27
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "TicoVac" or generic name "Tick-borne Encephalitis Vaccine"

NDCBrand NameGeneric Name
0069-0297TicoVacTick-Borne Encephalitis Vaccine
0069-0411TicoVacTick-Borne Encephalitis Vaccine

Trademark Results [TicoVac]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TICOVAC
TICOVAC
88797925 not registered Live/Pending
Pfizer Ireland Pharmaceuticals
2020-02-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.